1![HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati](https://www.pdfsearch.io/img/a8b33facecd687aedbe2b0a4e579024d.jpg "HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati") | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:51:21
|
|---|
2 | Add to Reading ListSource URL: www.pharma.us.novartis.comLanguage: English - Date: 2014-07-11 06:11:53
|
|---|
3 | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-05-13 14:54:58
|
|---|
4 | Add to Reading ListSource URL: www.health.gov.bc.caLanguage: English - Date: 2014-03-05 12:02:55
|
|---|
5![http://www.thepharmvoice.com[removed]wyeth_one_of_the_us_epas_b](https://www.pdfsearch.io/img/3a64a83ae67e59580c108343544ea6b8.jpg "http://www.thepharmvoice.com[removed]wyeth_one_of_the_us_epas_b") | Add to Reading ListSource URL: www.bestworkplaces.orgLanguage: English - Date: 2014-06-09 14:18:43
|
|---|
6 | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-01-29 10:27:23
|
|---|